UCB (EBR:UCB) UCB Media Room: Disposal of own shares
Transparency directive : regulatory news
09/09/2022 20:00
https://mb.cision.com/Public/18595/3628890/b532caec227679a2_800x800ar.png
** Disposal of own shares
------------------------------------------------------------
Brussels (Belgium), 9 September 2022 =E2=80=93 20:00 (CEST) =E2=80=93 Regul=
ated information=C2=A0
In accordance with article 8:6 of the Royal Decree executing the Belgian Co=
de of Companies and Associations, UCB announces that on 5 September 2022, i=
n accordance with the vesting rules under its 2020 and 2021 LTI plan, UCB S=
A/NV has delivered for free a total of 742 UCB shares OTC to 4 members of t=
he personnel of the Company and its subsidiaries. The highest independent b=
id price on Euronext Brussels on 5 September 2022 was =E2=82=AC 69.50.
This press release is available on UCB SA/NV=E2=80=99s website via the foll=
owing link (https://www.ucb.com/stories-media/Press-Releases) .
For further information, contact UCB:=C2=A0
Investor Relations
Antje Witte=C2=A0
T +32 2 559 94 14
antje.witte@ucb.com
Corporate Communications
Laurent Schots=C2=A0
T+32 2 559 92 64
laurent.schots@ucb.com =C2=A0=C2=A0 =C2=A0
About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company =
focused on the discovery and development of innovative medicines and soluti=
ons to transform the lives of people living with severe diseases of the imm=
une system or of the central nervous system. With approximately 8 600 peopl=
e in nearly 40 countries, the company generated revenue of =E2=82=AC 5.8 bi=
llion in 2021. UCB is listed on Euronext Brussels (symbol: UCB). Follow us =
on Twitter: @UCB_news
=C2=A0
GenericFile
220909 - Disposals of own shares ENG (https://mb.cision.com/Public/18595/36=
28890/b94f54101d82a991.pdf) GenericFile
220909 - Ali=C3=A9nation d actions propres FR (https://mb.cision.com/Public=
/18595/3628890/bb3c15c46205f707.pdf) GenericFile
220909 - Vervreemding van eigen aandelen NL (https://mb.cision.com/Public/1=
8595/3628890/a1673daa923a588f.pdf)
______________________
If you would rather not receive future communications from UCB SA, please g=
o to https://eu.vocuspr.com/OptOut.aspx?2973226x20421x115493x1x6868579x2400=
0x6&Email=3Dregnews%40symexglobal.com.
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium
UCB's latest news
26/04/2024 20:00
25/04/2024 18:00
25/04/2024 07:01
23/04/2024 20:00
22/04/2024 07:01
19/04/2024 20:00
17/04/2024 07:01
12/04/2024 20:00
12/04/2024 18:01
12/04/2024 07:01
Other stories
18/05/2024 04:03
17/05/2024 22:34
18/05/2024 07:34
17/05/2024 19:16
17/05/2024 21:48
17/05/2024 13:06
17/05/2024 19:08
17/05/2024 19:29
17/05/2024 23:20
17/05/2024 23:17
17/05/2024 22:50
18/05/2024 01:38
17/05/2024 16:26
17/05/2024 23:17
17/05/2024 21:56
17/05/2024 20:56
17/05/2024 13:44
17/05/2024 20:25
17/05/2024 22:22
17/05/2024 20:08
16/05/2024 23:30
17/05/2024 23:03
18/05/2024 07:59
18/05/2024 00:33
17/05/2024 17:37
18/05/2024 07:00
18/05/2024 03:31
18/05/2024 01:55
17/05/2024 22:54
17/05/2024 22:59
17/05/2024 01:00
17/05/2024 23:23
17/05/2024 22:00
17/05/2024 07:14
17/05/2024 22:10
17/05/2024 20:36
17/05/2024 17:11
17/05/2024 16:41